Biological Products, (No Diagnostic Substances) · DE · CIK 1840229
MiNK Therapeutics develops iNKT cell therapies for GvHD, solid tumors, and multiple myeloma
Comparable business profile · signals at a glance
In the 90 days to Mar 10, 2026: 1 sold $27K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Ryan BarbaraDirector | Sell | 500 | $15.57 | $8K |
| Mar 10, 2026 | Ryan BarbaraDirector | Sell | 500 | $15.30 | $8K |
| Mar 10, 2026 | Ryan BarbaraDirector | Sell | 300 | $15.28 | $5K |
| Mar 9, 2026 | Ryan BarbaraDirector | Sell | 200 | $10.17 | $2K |
| Mar 2, 2026 | Ryan BarbaraDirector | Sell | 100 | $10.83 | $1K |
| Feb 27, 2026 | Ryan BarbaraDirector | Sell | 400 | $10.86 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.